Thonburi Healthcare Group Public Company Limited(THG.BK)
No price history available.
Key financial summary
Financials in THB| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | THBm | 7,315 | 10,847 | 11,540 | 9,844 | 9,479 | 9,097 | N/A | N/A |
| Operating profit | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | THBm | 23 | 1,337 | 1,602 | 295 | -1,765 | 96 | N/A | N/A |
| EPS reported | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in THB| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Thonburi Healthcare Group Public Company Limited, alongside its affiliated entities, manages private hospitals throughout Thailand. The company's operations are divided into three primary segments: Medical Services, Healthcare Solution Provision, and Other Businesses. It offers a comprehensive range of medical treatments, encompassing specialized care in neurosciences, orthopedics, gastroenterology, cardiology, and obstetrics and gynecology. Additionally, the group provides management expertise for provincial government hospitals and heart centers across both public and private sectors. Its varied business interests also include offering elder care and senior living facilities, in-home healthcare services, and operating patient rehabilitation centers. Furthermore, the company engages in real estate development for senior housing, oversees elderly care facilities, and distributes a wide array of dental supply brands such as Adec, W&H, AO, Heraeus, Ivoclar, Megagen, SAM, Melag, and Alpro. Other ventures involve the retail sale of pharmaceuticals and medical supplies in specialized outlets, the creation of hospital management software, and broader property development. Thonburi Healthcare Group operates a network of hospitals that includes four facilities in or near Bangkok (Thonburi, Thonburi 2, Thonburi Bamrungmuang, and Thonburi Burana Hospital in Pathum Thani), four provincial hospitals (Rajyindee, Ubonrak Thonburi, Sirivej Chanthaburi, and Thonburi Thungsong), and one international hospital located in the Republic of the Union of Myanmar. Founded in 1976, the company maintains its headquarters in Bangkok, Thailand.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Thonburi Healthcare Group Public Company Limited (THG.BK)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Thonburi Healthcare Group Public Company Limited, alongside its affiliated entities, manages private hospitals throughout Thailand. The company's operations are divided into three primary segments: Medical Services, Healthcare Solution Provision, and Other Businesses. It offers a comprehensive range of medical treatments, encompassing specialized care in neurosciences, orthopedics, gastroenterology, cardiology, and obstetrics and gynecology. Additionally, the group provides management expertise for provincial government hospitals and heart centers across both public and private sectors. Its varied business interests also include offering elder care and senior living facilities, in-home healthcare services, and operating patient rehabilitation centers. Furthermore, the company engages in real estate development for senior housing, oversees elderly care facilities, and distributes a wide array of dental supply brands such as Adec, W&H, AO, Heraeus, Ivoclar, Megagen, SAM, Melag, and Alpro. Other ventures involve the retail sale of pharmaceuticals and medical supplies in specialized outlets, the creation of hospital management software, and broader property development. Thonburi Healthcare Group operates a network of hospitals that includes four facilities in or near Bangkok (Thonburi, Thonburi 2, Thonburi Bamrungmuang, and Thonburi Burana Hospital in Pathum Thani), four provincial hospitals (Rajyindee, Ubonrak Thonburi, Sirivej Chanthaburi, and Thonburi Thungsong), and one international hospital located in the Republic of the Union of Myanmar. Founded in 1976, the company maintains its headquarters in Bangkok, Thailand.